Table 1.
Characteristics | N = 33 |
---|---|
Median age at diagnosis (range, years) | 56 (26–80) |
Gender | |
Male | 20 |
Female | 13 |
Response to neoadjuvant therapy | |
pCR | 11 |
pIR | 22 |
Tumor regression grade | |
TRG0 | 11 |
TRG1 | 10 |
TRG2 | 9 |
TRG3 | 3 |
cT stage | |
T2 | 6 |
T3 | 25 |
T4 | 2 |
cN stage | |
N0 | 10 |
N+ | 23 |
ypT stage | |
T0 | 12 |
T1 | 1 |
T2 | 11 |
T3 | 7 |
T4 | 2 |
ypN stage | |
N0 | 27 |
N+ | 6 |
Metastasis | 5 |
Cell differentiation | |
Well | 8 |
Moderate | 24 |
NA | 1 |
TNM, tumor-node-metastasis (AJCC 7th edition); pCR, pathological complete response; pIR, pathological incomplete response; TRG, Tumor Regression Grade; NA, not available.